0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hybrid bio-artificial Ligament Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17R14231
Home | Market Reports | Health| Medical Devices & Equipment
Global Hybrid bio artificial Ligament Market Research Report 2023
BUY CHAPTERS

Global Hybrid bio-artificial Ligament Market Research Report 2025

Code: QYRE-Auto-17R14231
Report
May 2025
Pages:90
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Hybrid bio-artificial Ligament Market

The global market for Hybrid bio-artificial Ligament was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Artificial ligaments are devices used to replace damaged ligaments
North American market for Hybrid bio-artificial Ligament is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Hybrid bio-artificial Ligament is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Hybrid bio-artificial Ligament include Movmedix, Orthomed, Corin Group, Neoligaments, Biorez, FH ORTHO, Mathys, Teijin, Exactech, Cousin Biotech, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hybrid bio-artificial Ligament, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hybrid bio-artificial Ligament.
The Hybrid bio-artificial Ligament market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hybrid bio-artificial Ligament market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hybrid bio-artificial Ligament manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hybrid bio-artificial Ligament Market Report

Report Metric Details
Report Name Hybrid bio-artificial Ligament Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Movmedix, Orthomed, Corin Group, Neoligaments, Biorez, FH ORTHO, Mathys, Teijin, Exactech, Cousin Biotech, CoreTissue BioEngineering, Shanghai Pine & Power Biotech, Shanghai Ligatech Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hybrid bio-artificial Ligament manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hybrid bio-artificial Ligament in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Hybrid bio-artificial Ligament Market report?

Ans: The main players in the Hybrid bio-artificial Ligament Market are Movmedix, Orthomed, Corin Group, Neoligaments, Biorez, FH ORTHO, Mathys, Teijin, Exactech, Cousin Biotech, CoreTissue BioEngineering, Shanghai Pine & Power Biotech, Shanghai Ligatech Bioscience

What are the Application segmentation covered in the Hybrid bio-artificial Ligament Market report?

Ans: The Applications covered in the Hybrid bio-artificial Ligament Market report are Knee Injuries, Shoulder Injuries, Foot and Ankle Injuries, Other

What are the Type segmentation covered in the Hybrid bio-artificial Ligament Market report?

Ans: The Types covered in the Hybrid bio-artificial Ligament Market report are Anterior Cruciate Ligament (ACL), Posterior Cruciate Ligament (PCL), Medial Cruciate Ligament (MCL)

Recommended Reports

Orthopedic Implants

Artificial Organs & Tissues

Biomaterials & Medical Polymers

1 Hybrid bio-artificial Ligament Market Overview
1.1 Product Definition
1.2 Hybrid bio-artificial Ligament by Type
1.2.1 Global Hybrid bio-artificial Ligament Market Value Comparison by Type (2024 VS 2031)
1.2.2 Anterior Cruciate Ligament (ACL)
1.2.3 Posterior Cruciate Ligament (PCL)
1.2.4 Medial Cruciate Ligament (MCL)
1.3 Hybrid bio-artificial Ligament by Application
1.3.1 Global Hybrid bio-artificial Ligament Market Value by Application (2024 VS 2031)
1.3.2 Knee Injuries
1.3.3 Shoulder Injuries
1.3.4 Foot and Ankle Injuries
1.3.5 Other
1.4 Global Hybrid bio-artificial Ligament Market Size Estimates and Forecasts
1.4.1 Global Hybrid bio-artificial Ligament Revenue 2020-2031
1.4.2 Global Hybrid bio-artificial Ligament Sales 2020-2031
1.4.3 Global Hybrid bio-artificial Ligament Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hybrid bio-artificial Ligament Market Competition by Manufacturers
2.1 Global Hybrid bio-artificial Ligament Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hybrid bio-artificial Ligament Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hybrid bio-artificial Ligament Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hybrid bio-artificial Ligament, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hybrid bio-artificial Ligament, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hybrid bio-artificial Ligament, Product Type & Application
2.7 Global Key Manufacturers of Hybrid bio-artificial Ligament, Date of Enter into This Industry
2.8 Global Hybrid bio-artificial Ligament Market Competitive Situation and Trends
2.8.1 Global Hybrid bio-artificial Ligament Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hybrid bio-artificial Ligament Players Market Share by Revenue
2.8.3 Global Hybrid bio-artificial Ligament Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hybrid bio-artificial Ligament Market Scenario by Region
3.1 Global Hybrid bio-artificial Ligament Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hybrid bio-artificial Ligament Sales by Region: 2020-2031
3.2.1 Global Hybrid bio-artificial Ligament Sales by Region: 2020-2025
3.2.2 Global Hybrid bio-artificial Ligament Sales by Region: 2026-2031
3.3 Global Hybrid bio-artificial Ligament Revenue by Region: 2020-2031
3.3.1 Global Hybrid bio-artificial Ligament Revenue by Region: 2020-2025
3.3.2 Global Hybrid bio-artificial Ligament Revenue by Region: 2026-2031
3.4 North America Hybrid bio-artificial Ligament Market Facts & Figures by Country
3.4.1 North America Hybrid bio-artificial Ligament Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hybrid bio-artificial Ligament Sales by Country (2020-2031)
3.4.3 North America Hybrid bio-artificial Ligament Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hybrid bio-artificial Ligament Market Facts & Figures by Country
3.5.1 Europe Hybrid bio-artificial Ligament Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hybrid bio-artificial Ligament Sales by Country (2020-2031)
3.5.3 Europe Hybrid bio-artificial Ligament Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hybrid bio-artificial Ligament Market Facts & Figures by Region
3.6.1 Asia Pacific Hybrid bio-artificial Ligament Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hybrid bio-artificial Ligament Sales by Region (2020-2031)
3.6.3 Asia Pacific Hybrid bio-artificial Ligament Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hybrid bio-artificial Ligament Market Facts & Figures by Country
3.7.1 Latin America Hybrid bio-artificial Ligament Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hybrid bio-artificial Ligament Sales by Country (2020-2031)
3.7.3 Latin America Hybrid bio-artificial Ligament Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hybrid bio-artificial Ligament Market Facts & Figures by Country
3.8.1 Middle East and Africa Hybrid bio-artificial Ligament Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hybrid bio-artificial Ligament Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hybrid bio-artificial Ligament Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hybrid bio-artificial Ligament Sales by Type (2020-2031)
4.1.1 Global Hybrid bio-artificial Ligament Sales by Type (2020-2025)
4.1.2 Global Hybrid bio-artificial Ligament Sales by Type (2026-2031)
4.1.3 Global Hybrid bio-artificial Ligament Sales Market Share by Type (2020-2031)
4.2 Global Hybrid bio-artificial Ligament Revenue by Type (2020-2031)
4.2.1 Global Hybrid bio-artificial Ligament Revenue by Type (2020-2025)
4.2.2 Global Hybrid bio-artificial Ligament Revenue by Type (2026-2031)
4.2.3 Global Hybrid bio-artificial Ligament Revenue Market Share by Type (2020-2031)
4.3 Global Hybrid bio-artificial Ligament Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hybrid bio-artificial Ligament Sales by Application (2020-2031)
5.1.1 Global Hybrid bio-artificial Ligament Sales by Application (2020-2025)
5.1.2 Global Hybrid bio-artificial Ligament Sales by Application (2026-2031)
5.1.3 Global Hybrid bio-artificial Ligament Sales Market Share by Application (2020-2031)
5.2 Global Hybrid bio-artificial Ligament Revenue by Application (2020-2031)
5.2.1 Global Hybrid bio-artificial Ligament Revenue by Application (2020-2025)
5.2.2 Global Hybrid bio-artificial Ligament Revenue by Application (2026-2031)
5.2.3 Global Hybrid bio-artificial Ligament Revenue Market Share by Application (2020-2031)
5.3 Global Hybrid bio-artificial Ligament Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Movmedix
6.1.1 Movmedix Company Information
6.1.2 Movmedix Description and Business Overview
6.1.3 Movmedix Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Movmedix Hybrid bio-artificial Ligament Product Portfolio
6.1.5 Movmedix Recent Developments/Updates
6.2 Orthomed
6.2.1 Orthomed Company Information
6.2.2 Orthomed Description and Business Overview
6.2.3 Orthomed Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Orthomed Hybrid bio-artificial Ligament Product Portfolio
6.2.5 Orthomed Recent Developments/Updates
6.3 Corin Group
6.3.1 Corin Group Company Information
6.3.2 Corin Group Description and Business Overview
6.3.3 Corin Group Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Corin Group Hybrid bio-artificial Ligament Product Portfolio
6.3.5 Corin Group Recent Developments/Updates
6.4 Neoligaments
6.4.1 Neoligaments Company Information
6.4.2 Neoligaments Description and Business Overview
6.4.3 Neoligaments Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Neoligaments Hybrid bio-artificial Ligament Product Portfolio
6.4.5 Neoligaments Recent Developments/Updates
6.5 Biorez
6.5.1 Biorez Company Information
6.5.2 Biorez Description and Business Overview
6.5.3 Biorez Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Biorez Hybrid bio-artificial Ligament Product Portfolio
6.5.5 Biorez Recent Developments/Updates
6.6 FH ORTHO
6.6.1 FH ORTHO Company Information
6.6.2 FH ORTHO Description and Business Overview
6.6.3 FH ORTHO Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.6.4 FH ORTHO Hybrid bio-artificial Ligament Product Portfolio
6.6.5 FH ORTHO Recent Developments/Updates
6.7 Mathys
6.7.1 Mathys Company Information
6.7.2 Mathys Description and Business Overview
6.7.3 Mathys Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Mathys Hybrid bio-artificial Ligament Product Portfolio
6.7.5 Mathys Recent Developments/Updates
6.8 Teijin
6.8.1 Teijin Company Information
6.8.2 Teijin Description and Business Overview
6.8.3 Teijin Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Teijin Hybrid bio-artificial Ligament Product Portfolio
6.8.5 Teijin Recent Developments/Updates
6.9 Exactech
6.9.1 Exactech Company Information
6.9.2 Exactech Description and Business Overview
6.9.3 Exactech Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Exactech Hybrid bio-artificial Ligament Product Portfolio
6.9.5 Exactech Recent Developments/Updates
6.10 Cousin Biotech
6.10.1 Cousin Biotech Company Information
6.10.2 Cousin Biotech Description and Business Overview
6.10.3 Cousin Biotech Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Cousin Biotech Hybrid bio-artificial Ligament Product Portfolio
6.10.5 Cousin Biotech Recent Developments/Updates
6.11 CoreTissue BioEngineering
6.11.1 CoreTissue BioEngineering Company Information
6.11.2 CoreTissue BioEngineering Description and Business Overview
6.11.3 CoreTissue BioEngineering Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.11.4 CoreTissue BioEngineering Hybrid bio-artificial Ligament Product Portfolio
6.11.5 CoreTissue BioEngineering Recent Developments/Updates
6.12 Shanghai Pine & Power Biotech
6.12.1 Shanghai Pine & Power Biotech Company Information
6.12.2 Shanghai Pine & Power Biotech Description and Business Overview
6.12.3 Shanghai Pine & Power Biotech Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Shanghai Pine & Power Biotech Hybrid bio-artificial Ligament Product Portfolio
6.12.5 Shanghai Pine & Power Biotech Recent Developments/Updates
6.13 Shanghai Ligatech Bioscience
6.13.1 Shanghai Ligatech Bioscience Company Information
6.13.2 Shanghai Ligatech Bioscience Description and Business Overview
6.13.3 Shanghai Ligatech Bioscience Hybrid bio-artificial Ligament Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Shanghai Ligatech Bioscience Hybrid bio-artificial Ligament Product Portfolio
6.13.5 Shanghai Ligatech Bioscience Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hybrid bio-artificial Ligament Industry Chain Analysis
7.2 Hybrid bio-artificial Ligament Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hybrid bio-artificial Ligament Production Mode & Process Analysis
7.4 Hybrid bio-artificial Ligament Sales and Marketing
7.4.1 Hybrid bio-artificial Ligament Sales Channels
7.4.2 Hybrid bio-artificial Ligament Distributors
7.5 Hybrid bio-artificial Ligament Customer Analysis
8 Hybrid bio-artificial Ligament Market Dynamics
8.1 Hybrid bio-artificial Ligament Industry Trends
8.2 Hybrid bio-artificial Ligament Market Drivers
8.3 Hybrid bio-artificial Ligament Market Challenges
8.4 Hybrid bio-artificial Ligament Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Hybrid bio-artificial Ligament Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hybrid bio-artificial Ligament Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hybrid bio-artificial Ligament Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hybrid bio-artificial Ligament Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hybrid bio-artificial Ligament Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hybrid bio-artificial Ligament Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hybrid bio-artificial Ligament Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hybrid bio-artificial Ligament Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hybrid bio-artificial Ligament, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hybrid bio-artificial Ligament, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hybrid bio-artificial Ligament, Product Type & Application
 Table 12. Global Key Manufacturers of Hybrid bio-artificial Ligament, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hybrid bio-artificial Ligament by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hybrid bio-artificial Ligament as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hybrid bio-artificial Ligament Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hybrid bio-artificial Ligament Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hybrid bio-artificial Ligament Sales Market Share by Region (2020-2025)
 Table 19. Global Hybrid bio-artificial Ligament Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hybrid bio-artificial Ligament Sales Market Share by Region (2026-2031)
 Table 21. Global Hybrid bio-artificial Ligament Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hybrid bio-artificial Ligament Revenue Market Share by Region (2020-2025)
 Table 23. Global Hybrid bio-artificial Ligament Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hybrid bio-artificial Ligament Revenue Market Share by Region (2026-2031)
 Table 25. North America Hybrid bio-artificial Ligament Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hybrid bio-artificial Ligament Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hybrid bio-artificial Ligament Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hybrid bio-artificial Ligament Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hybrid bio-artificial Ligament Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hybrid bio-artificial Ligament Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hybrid bio-artificial Ligament Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hybrid bio-artificial Ligament Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hybrid bio-artificial Ligament Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hybrid bio-artificial Ligament Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hybrid bio-artificial Ligament Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hybrid bio-artificial Ligament Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hybrid bio-artificial Ligament Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hybrid bio-artificial Ligament Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hybrid bio-artificial Ligament Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hybrid bio-artificial Ligament Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hybrid bio-artificial Ligament Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hybrid bio-artificial Ligament Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hybrid bio-artificial Ligament Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hybrid bio-artificial Ligament Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hybrid bio-artificial Ligament Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hybrid bio-artificial Ligament Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hybrid bio-artificial Ligament Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hybrid bio-artificial Ligament Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hybrid bio-artificial Ligament Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hybrid bio-artificial Ligament Sales (K Units) by Type (2020-2025)
 Table 51. Global Hybrid bio-artificial Ligament Sales (K Units) by Type (2026-2031)
 Table 52. Global Hybrid bio-artificial Ligament Sales Market Share by Type (2020-2025)
 Table 53. Global Hybrid bio-artificial Ligament Sales Market Share by Type (2026-2031)
 Table 54. Global Hybrid bio-artificial Ligament Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hybrid bio-artificial Ligament Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hybrid bio-artificial Ligament Revenue Market Share by Type (2020-2025)
 Table 57. Global Hybrid bio-artificial Ligament Revenue Market Share by Type (2026-2031)
 Table 58. Global Hybrid bio-artificial Ligament Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hybrid bio-artificial Ligament Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hybrid bio-artificial Ligament Sales (K Units) by Application (2020-2025)
 Table 61. Global Hybrid bio-artificial Ligament Sales (K Units) by Application (2026-2031)
 Table 62. Global Hybrid bio-artificial Ligament Sales Market Share by Application (2020-2025)
 Table 63. Global Hybrid bio-artificial Ligament Sales Market Share by Application (2026-2031)
 Table 64. Global Hybrid bio-artificial Ligament Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hybrid bio-artificial Ligament Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hybrid bio-artificial Ligament Revenue Market Share by Application (2020-2025)
 Table 67. Global Hybrid bio-artificial Ligament Revenue Market Share by Application (2026-2031)
 Table 68. Global Hybrid bio-artificial Ligament Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hybrid bio-artificial Ligament Price (US$/Unit) by Application (2026-2031)
 Table 70. Movmedix Company Information
 Table 71. Movmedix Description and Business Overview
 Table 72. Movmedix Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Movmedix Hybrid bio-artificial Ligament Product
 Table 74. Movmedix Recent Developments/Updates
 Table 75. Orthomed Company Information
 Table 76. Orthomed Description and Business Overview
 Table 77. Orthomed Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Orthomed Hybrid bio-artificial Ligament Product
 Table 79. Orthomed Recent Developments/Updates
 Table 80. Corin Group Company Information
 Table 81. Corin Group Description and Business Overview
 Table 82. Corin Group Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Corin Group Hybrid bio-artificial Ligament Product
 Table 84. Corin Group Recent Developments/Updates
 Table 85. Neoligaments Company Information
 Table 86. Neoligaments Description and Business Overview
 Table 87. Neoligaments Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Neoligaments Hybrid bio-artificial Ligament Product
 Table 89. Neoligaments Recent Developments/Updates
 Table 90. Biorez Company Information
 Table 91. Biorez Description and Business Overview
 Table 92. Biorez Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Biorez Hybrid bio-artificial Ligament Product
 Table 94. Biorez Recent Developments/Updates
 Table 95. FH ORTHO Company Information
 Table 96. FH ORTHO Description and Business Overview
 Table 97. FH ORTHO Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. FH ORTHO Hybrid bio-artificial Ligament Product
 Table 99. FH ORTHO Recent Developments/Updates
 Table 100. Mathys Company Information
 Table 101. Mathys Description and Business Overview
 Table 102. Mathys Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Mathys Hybrid bio-artificial Ligament Product
 Table 104. Mathys Recent Developments/Updates
 Table 105. Teijin Company Information
 Table 106. Teijin Description and Business Overview
 Table 107. Teijin Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Teijin Hybrid bio-artificial Ligament Product
 Table 109. Teijin Recent Developments/Updates
 Table 110. Exactech Company Information
 Table 111. Exactech Description and Business Overview
 Table 112. Exactech Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Exactech Hybrid bio-artificial Ligament Product
 Table 114. Exactech Recent Developments/Updates
 Table 115. Cousin Biotech Company Information
 Table 116. Cousin Biotech Description and Business Overview
 Table 117. Cousin Biotech Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Cousin Biotech Hybrid bio-artificial Ligament Product
 Table 119. Cousin Biotech Recent Developments/Updates
 Table 120. CoreTissue BioEngineering Company Information
 Table 121. CoreTissue BioEngineering Description and Business Overview
 Table 122. CoreTissue BioEngineering Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. CoreTissue BioEngineering Hybrid bio-artificial Ligament Product
 Table 124. CoreTissue BioEngineering Recent Developments/Updates
 Table 125. Shanghai Pine & Power Biotech Company Information
 Table 126. Shanghai Pine & Power Biotech Description and Business Overview
 Table 127. Shanghai Pine & Power Biotech Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Shanghai Pine & Power Biotech Hybrid bio-artificial Ligament Product
 Table 129. Shanghai Pine & Power Biotech Recent Developments/Updates
 Table 130. Shanghai Ligatech Bioscience Company Information
 Table 131. Shanghai Ligatech Bioscience Description and Business Overview
 Table 132. Shanghai Ligatech Bioscience Hybrid bio-artificial Ligament Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Shanghai Ligatech Bioscience Hybrid bio-artificial Ligament Product
 Table 134. Shanghai Ligatech Bioscience Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Hybrid bio-artificial Ligament Distributors List
 Table 138. Hybrid bio-artificial Ligament Customers List
 Table 139. Hybrid bio-artificial Ligament Market Trends
 Table 140. Hybrid bio-artificial Ligament Market Drivers
 Table 141. Hybrid bio-artificial Ligament Market Challenges
 Table 142. Hybrid bio-artificial Ligament Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hybrid bio-artificial Ligament
 Figure 2. Global Hybrid bio-artificial Ligament Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hybrid bio-artificial Ligament Market Share by Type: 2024 & 2031
 Figure 4. Anterior Cruciate Ligament (ACL) Product Picture
 Figure 5. Posterior Cruciate Ligament (PCL) Product Picture
 Figure 6. Medial Cruciate Ligament (MCL) Product Picture
 Figure 7. Global Hybrid bio-artificial Ligament Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Hybrid bio-artificial Ligament Market Share by Application: 2024 & 2031
 Figure 9. Knee Injuries
 Figure 10. Shoulder Injuries
 Figure 11. Foot and Ankle Injuries
 Figure 12. Other
 Figure 13. Global Hybrid bio-artificial Ligament Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Hybrid bio-artificial Ligament Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Hybrid bio-artificial Ligament Sales (2020-2031) & (K Units)
 Figure 16. Global Hybrid bio-artificial Ligament Average Price (US$/Unit) & (2020-2031)
 Figure 17. Hybrid bio-artificial Ligament Report Years Considered
 Figure 18. Hybrid bio-artificial Ligament Sales Share by Manufacturers in 2024
 Figure 19. Global Hybrid bio-artificial Ligament Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Hybrid bio-artificial Ligament Players: Market Share by Revenue in Hybrid bio-artificial Ligament in 2024
 Figure 21. Hybrid bio-artificial Ligament Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Hybrid bio-artificial Ligament Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Hybrid bio-artificial Ligament Sales Market Share by Country (2020-2031)
 Figure 24. North America Hybrid bio-artificial Ligament Revenue Market Share by Country (2020-2031)
 Figure 25. United States Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Hybrid bio-artificial Ligament Sales Market Share by Country (2020-2031)
 Figure 28. Europe Hybrid bio-artificial Ligament Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Hybrid bio-artificial Ligament Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Hybrid bio-artificial Ligament Revenue Market Share by Region (2020-2031)
 Figure 36. China Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Hybrid bio-artificial Ligament Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Hybrid bio-artificial Ligament Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Colombia Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Hybrid bio-artificial Ligament Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Hybrid bio-artificial Ligament Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Hybrid bio-artificial Ligament Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Hybrid bio-artificial Ligament by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Hybrid bio-artificial Ligament by Type (2020-2031)
 Figure 56. Global Hybrid bio-artificial Ligament Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Hybrid bio-artificial Ligament by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Hybrid bio-artificial Ligament by Application (2020-2031)
 Figure 59. Global Hybrid bio-artificial Ligament Price (US$/Unit) by Application (2020-2031)
 Figure 60. Hybrid bio-artificial Ligament Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart